ARTICLE | Company News
MorphoSys Alzheimer's deal with Roche
September 11, 2000 7:00 AM UTC
MorphoSys (NMarkt:MOR) will use its HuCAL Fab technology to develop antibodies against a target from Roche (SWX:ROCZ). MOR will receive an upfront payment and be eligible for milestones and royalties ...